Show
Sort by
-
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
EUFOREA consensus on biologics for CRSwNP with or without asthma
-
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
-
Adherence to treatment in allergic rhinitis using mobile technology : the MASK study
-
Allergic Rhinitis and its Impact on Asthma (ARIA) phase 4 (2018) : change management in allergic rhinitis and asthma multimorbidity using mobile technology
-
- Journal Article
- A1
- open access
Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases
-
Endotype-driven care pathways in patients with chronic rhinosinusitis
-
Rhinology future debates 2017 by EUFOREA : novel treatments and surgical solutions in rhinology
-
Atopic comorbidities and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) who failed intranasal corticosteroids
-
- Journal Article
- A1
- open access
Impact of rhinitis on work productivity : a systematic review